Cargando…

Acute respiratory distress syndrome after the use of gadolinium contrast agent

Acute respiratory distress syndrome (ARDS) is a life-threatening medical emergency. The etiology of ARDS can involve various causes. ARDS associated with the use of iodinated contrast media is rarely reported, and the literature includes only one case of ARDS due to gadobutrol. A 46-year-old female...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kerget, Bugra, Aksakal, Alperen, Afşin, Dursun Erol, Araz, Omer, Ucar, Elif Yılmazel, Akgün, Metin, Sağlam, Leyla
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223103/ https://www.ncbi.nlm.nih.gov/pubmed/30450277 http://dx.doi.org/10.1016/j.rmcr.2018.10.018

Ejemplares similares

Acute respiratory distress syndrome; A rare complication caused by usage of ruxolitinib
por: Kerget, Bugra, et al.
Publicado: (2017)

Could HIF-1α be a novel biomarker for the clinical course and treatment of pulmonary embolism?
por: KERGET, Buğra, et al.
Publicado: (2020)

The role of systemic immune-inflammation index (SII) in the differential diagnosis of granulomatous and reactive LAP diagnosed by endobronchial ultrasonography
por: Kerget, Buğra, et al.
Publicado: (2023)

Are Serum Interleukin 6 and Surfactant Protein D Levels Associated with the Clinical Course of COVID-19?
por: Kerget, Buğra, et al.
Publicado: (2020)

Effectiveness of pharmacologic therapies on smoking cessation success: three years results of a smoking cessation clinic
por: Yilmazel Ucar, Elif, et al.
Publicado: (2014)

Two different dosages of nebulized steroid versus parenteral steroid in the management of COPD exacerbations: A randomized control trial
por: Ucar, Elif Yilmazel, et al.
Publicado: (2014)

Is atmospheric pressure change an Independent risk factor for hemoptysis?
por: Araz, Omer, et al.
Publicado: (2014)

The relationship between NLRP3 rs10159239 and Vaspin rs2236242 gene variants and obstructive sleep apnea
por: Kerget, Buğra, et al.
Publicado: (2021)

The incidence and severity of pulmonary hypertension in obstructive sleep apnea with hypothyroidism
por: Araz, Omer, et al.
Publicado: (2013)

The role of exhaled nitric oxide (FeNO) in the evaluation of lung parenchymal involvement in COVID-19 patients
por: Kerget, Buğra, et al.
Publicado: (2022)

Comparison of two antifibrotic treatments for lung fibrosis in post-COVID-19 syndrome: A randomized, prospective study
por: Kerget, Buğra, et al.
Publicado: (2023)

Comparison of two antifibrotic treatments for lung fibrosis in post-COVID-19 syndrome: A randomized, prospective study
por: Kerget, Buğra, et al.
Publicado: (2023)

Evaluation of Exhaled Carbon Monoxide Levels in Individuals Exposed to Passive Tobacco Smoke in Indoor and Outdoor Environments: How Far Can We Getaway Under the Same Roof?
por: Afşin, Dursun E, et al.
Publicado: (2023)

Comparison of reducing effect on lung injury of dexamethasone and bosentan in acute lung injury: an experimental study
por: Araz, Omer, et al.
Publicado: (2013)

The association of human leukocyte antigen polymorphisms with disease severity and latency period in patients with silicosis
por: Dogan, Hasan, et al.
Publicado: (2014)

High-Frequency Chest Wall Oscillation in Patients with COVID-19: A Pilot Feasibility Study
por: Çelik, Mine, et al.
Publicado: (2022)

Late-onset acute respiratory distress syndrome induced by a gadolinium-based contrast agent
por: Kato, Kazuhiko, et al.
Publicado: (2019)

Acute respiratory distress syndrome following administration of gadolinium contrast agent: a case report
por: Osawa, Eduardo Atsushi, et al.
Publicado: (2022)

Acute Respiratory Distress Syndrome after the Use of Gadolinium Contrast Media
por: Park, Jihye, et al.
Publicado: (2015)

Gadolinium contrast agents: Over exposure?
por: Biederman, Robert W, et al.
Publicado: (2016)

Gadolinium-DTPA: A New Contrast Agent
por: Niendorf, H. P.
Publicado: (1988)

Evaluation of IGFBP5 expression and plasma osteopontin level in COVID-19 patients
por: Karabulut Uzunçakmak, Sevgi, et al.
Publicado: (2023)

Linear Gadolinium-Based Contrast Agents Are Associated With Brain Gadolinium Retention in Healthy Rats
por: Robert, Philippe, et al.
Publicado: (2016)

Gadolinium Complexes as Contrast Agent for Cellular NMR Spectroscopy
por: Sakol, Nat, et al.
Publicado: (2020)

Biocompatible Polyhydroxyethylaspartamide-based Micelles with Gadolinium for MRI Contrast Agents
por: Jeong, Sang Young, et al.
Publicado: (2010)

Immediate reaction to gadolinium based contrast agent with fatal outcome()()()
por: Behzadi, Ashkan Heshmatzadeh, et al.
Publicado: (2018)

Gadolinium-Based Contrast Agents Hypersensitivity: A Case Series
por: Nucera, Eleonora, et al.
Publicado: (2021)

Gadolinium-based contrast agents in neurofibromatosis type 1 (Review)
por: Năstase, Florentina, et al.
Publicado: (2021)

Recent Advances in Gadolinium Based Contrast Agents for Bioimaging Applications
por: Fatima, Atiya, et al.
Publicado: (2021)

The presence of the gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity - A systematic review
por: Olchowy, Cyprian, et al.
Publicado: (2017)

Gadolinium deposition in the brain of dogs after multiple intravenous administrations of linear gadolinium based contrast agents
por: Richter, Henning, et al.
Publicado: (2020)

Geometrical confinement of gadolinium-based contrast agents in nanoporous particles enhances T(1) contrast
por: Ananta, Jeyarama S., et al.
Publicado: (2010)

Gadolinium retention within multiple rat organs after intra-articular administration of gadolinium-based contrast agents
por: Ringler, Michael D., et al.
Publicado: (2021)

Gadolinium Retention in the Brain of Mother and Pup Mouse: Effect of Pregnancy and Repeated Administration of Gadolinium‐Based Contrast Agents
por: Yao, Xiang, et al.
Publicado: (2022)

Thermal Excitation of Gadolinium-Based Contrast Agents Using Spin Resonance
por: Dinger, Steven C., et al.
Publicado: (2016)

The New Restrictions on the Use of Linear Gadolinium-based Contrast Agents in Japan
por: Kanda, Tomonori
Publicado: (2018)

Effect of different doses of gadolinium contrast agent on clinical outcomes in MS
por: Ackermans, Nathalie, et al.
Publicado: (2019)

Investigating the Impact of Gadolinium-Based Contrast Agents on the Corrected QT Interval
por: Gress, Kyle L, et al.
Publicado: (2020)

PEG-modified gadolinium nanoparticles as contrast agents for in vivo micro-CT
por: Cruje, Charmainne, et al.
Publicado: (2021)

Formation of gadolinium–ferritin from clinical magnetic resonance contrast agents
por: Neburkova, Jitka, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_raml9nakuh4mhn8sq9c610jdea